Table 4.
SNM vs. BonT-A | % <Cost-effective threshold | ||
---|---|---|---|
| |||
Mean | Low range | High range | |
| |||
1 year | 0.50% | 0.10% | 0.40% |
2 years | 26.70% | 21.60% | 48.60% |
4 years | 94.40% | 95.60% | 93.90% |
5 years | 93.20% | 94.60% | 89.40% |
10 years | 85.80% | 88.60% | 77.70% |
SNM vs. OMT | % <Cost-effective threshold | ||
---|---|---|---|
| |||
Mean | Low range | High range | |
| |||
1 year | 17.90% | 22.00% | 9.40% |
2 years | 99.90% | 99.80% | 100.00% |
4 years | 99.60% | 99.60% | 100.00% |
5 years | 99.60% | 99.60% | 100.00% |
10 years | 64.70% | 61.40% | 78.00% |
QALY: quality-adjusted life years; SNM: sacral-neuromodulation; BonT-A: botulinum-toxin-A; OMT: optimized medical-therapy.